Company news
Gni Group Ltd. (TSE:2160) news
Gni Group Ltd. news releases on 6ix. Latest, Sep 3, 2026: Promotion of Proprietary Brand Business in the Medtech Segment
Press releases & updates
Promotion of Proprietary Brand Business in the Medtech Segment
September 2, 2026
Notice Regarding Change in Major Shareholder
August 23, 2026
Q2 FY2026 Financial Results Corporate Presentation
August 18, 2026
Consolidated Financial Results for Q2 FY2026 (IFRS)
August 14, 2026
Notice Concerning the Completion of the Acquisition of All Shares of AYUMI Pharmaceutical Holdings KK (Conversion into a Wholly-Owned Subsidiary)
July 1, 2026
Notice Regarding the Execution of a Loan Agreement Containing Financial Covenants
June 26, 2026
Notice Concerning Filing of Form S-3 Registration Statement by Gyre Therapeutics
June 23, 2026
GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
June 7, 2026
Transformational Acquisition of Ayumi Pharmaceutical Holdings
June 5, 2026
GNI : Financial Results Briefing for Q2 FY 2025 (on August 29, 2025)
August 28, 2025
GNI : FY2023Q1 Earnings Call Transcript
May 22, 2023
GNI : Amendment of “Q1 FY2023 Financial Results Corporate Presentation” document
May 18, 2023
GNI : Q1 FY2023 Financial Results Corporate Presentation
May 17, 2023
GNI : CBIO files 2023Q1 10-Q (quarterly report)
May 15, 2023
GNI : Consolidated Financial Results for Q1 FY2023(IFRS)
May 15, 2023
GNI : Amendment of "FY2022 Financial Results Corporate Presentation" document
March 7, 2023
GNI : Amendment of "FY2022 difference between forecast and actual" document
March 7, 2023
GNI : Amendment of "Consolidated Financial Results for FY2022(IFRS)" document
March 7, 2023
GNI : Consolidated Financial Results for FY2022(IFRS)
February 15, 2023